Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

    Neuro-Oncology, Vol. 26, Núm. 7, pp. 1230-1246